comunicacio

Cervical cytologies are not sensitive enough to detect endometrial cancer

The screening programs of cervical cancers diagnosticated by cervical cytologies have reduced the incidence and mortality of this cancer. However, a retrospective study of IDIBELL and ICO that included 371 women treated at the Hospital de Bellvitge has shown that these tests are not effective for endometrial cancer diagnosis.

Cervical cytologies are not sensitive enough to detect endometrial cancer Read More »

IDIBELL participates in a study aimed to reduce the likelihood of liver failure in older transplant donors

MCJ protein silencing emerges as a new therapy to prevent liver failure after ischaemia-reperfusion in models of metabolic syndrome and ageing.

IDIBELL participates in a study aimed to reduce the likelihood of liver failure in older transplant donors Read More »

An indicator of endothelial dysfunction predicts the need for ICU transfer in patients with bone marrow transplantation

The hematology team, from IDIBELL and ICO, has published an article in the journal Blood Advances that proposes this index as a tool to identify patients with higher risk to be transferred to the Intensive Care Unit (ICU) after hematopoietic stem cell transplant.

An indicator of endothelial dysfunction predicts the need for ICU transfer in patients with bone marrow transplantation Read More »

A new drug increases the life expectancy of patients with very aggressive intraocular cancer

The results of a clinical trial, published in the New England Journal of Medicine, show that Tebentafusp is the first drug to increase overall survival in metastatic uveal melanoma, highly aggressive cancer that causes death in 50% of cases in less than a year.

A new drug increases the life expectancy of patients with very aggressive intraocular cancer Read More »

IDIBELL receives a grant from the Generalitat to promote Personalized Medicine on campus

The Generalitat of Catalonia has awarded IDIBELL a co-financed project of 2 million euros that will consolidate Personalized Medicine on the Bellvitge campus. The money will be used to create and improve infrastructures that allow the management and storage of patient samples and derived data, ensuring their integrity and traceability.

IDIBELL receives a grant from the Generalitat to promote Personalized Medicine on campus Read More »

Scroll to Top